| Product Code: ETC327868 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Indonesia hepatitis vaccine market is estimated to reach USD 206.9 million by 2031, growing at a CAGR of 6.8% during the forecast period. Of the total cases registered in 2018, 54% were caused by hepatitis B virus and 46% by hepatitis A virus (HAV). Moreover, the rising burden of infectious diseases has led to an increased demand for preventive vaccines in Indonesia`s healthcare sector over the past few years. The government of Indonesia also initiated public awareness campaigns about vaccinations to reduce new infections among children and adults alike.
The demand for hepatitis vaccines could be influenced by government vaccination programs aimed at preventing the spread of hepatitis infections. Public health initiatives, rising awareness about vaccine-preventable diseases, and efforts to reduce the burden of hepatitis could drive the growth of this market.
The hepatitis vaccine market may face challenges related to vaccine accessibility and distribution, especially in remote or underserved areas of the country. Ensuring that vaccines reach the target population and are stored and administered properly to maintain their efficacy could be a logistical hurdle. Public awareness campaigns and effective healthcare infrastructure are key factors in addressing these challenges.
The pandemic brought a heightened focus on healthcare systems and vaccine development. It`s possible that the attention on vaccines could have impacted the hepatitis vaccine market, with resources potentially diverted towards COVID-19 vaccine efforts.
Major participants might involve global pharmaceutical companies with vaccine divisions such as GlaxoSmithKline (GSK), Merck & Co., and Sanofi Pasteur, along with potential collaborations with Indonesian health authorities.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Hepatitis Vaccine Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Hepatitis Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Hepatitis Vaccine Market - Industry Life Cycle |
3.4 Indonesia Hepatitis Vaccine Market - Porter's Five Forces |
3.5 Indonesia Hepatitis Vaccine Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Indonesia Hepatitis Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Indonesia Hepatitis Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Indonesia Hepatitis Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination and preventive healthcare measures in Indonesia |
4.2.2 Government initiatives and programs to promote vaccination and control the spread of hepatitis |
4.2.3 Growing investment in healthcare infrastructure and facilities in Indonesia |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas of Indonesia |
4.3.2 High cost associated with hepatitis vaccines and vaccination programs |
4.3.3 Lack of public awareness about the different types of hepatitis and the need for vaccination |
5 Indonesia Hepatitis Vaccine Market Trends |
6 Indonesia Hepatitis Vaccine Market, By Types |
6.1 Indonesia Hepatitis Vaccine Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Hepatitis Vaccine Market Revenues & Volume, By Indication, 2021-2031F |
6.1.3 Indonesia Hepatitis Vaccine Market Revenues & Volume, By Hepatitis A, 2021-2031F |
6.1.4 Indonesia Hepatitis Vaccine Market Revenues & Volume, By Hepatitis B, 2021-2031F |
6.2 Indonesia Hepatitis Vaccine Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Hepatitis Vaccine Market Revenues & Volume, By Recombinant Vaccine, 2021-2031F |
6.2.3 Indonesia Hepatitis Vaccine Market Revenues & Volume, By Inactivated Vaccine, 2021-2031F |
6.3 Indonesia Hepatitis Vaccine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Hepatitis Vaccine Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.3 Indonesia Hepatitis Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.3.4 Indonesia Hepatitis Vaccine Market Revenues & Volume, By Online Pharmacy, 2021-2031F |
7 Indonesia Hepatitis Vaccine Market Import-Export Trade Statistics |
7.1 Indonesia Hepatitis Vaccine Market Export to Major Countries |
7.2 Indonesia Hepatitis Vaccine Market Imports from Major Countries |
8 Indonesia Hepatitis Vaccine Market Key Performance Indicators |
8.1 Percentage increase in the number of vaccination centers offering hepatitis vaccines |
8.2 Rate of adoption of new vaccination technologies and practices in Indonesia |
8.3 Number of educational campaigns and programs organized to raise awareness about hepatitis vaccination |
9 Indonesia Hepatitis Vaccine Market - Opportunity Assessment |
9.1 Indonesia Hepatitis Vaccine Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Indonesia Hepatitis Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.3 Indonesia Hepatitis Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Indonesia Hepatitis Vaccine Market - Competitive Landscape |
10.1 Indonesia Hepatitis Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Hepatitis Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |